RESET-PSVT is intended to generate prospective evidence to inform the real-world use of recently approved CARDAMYST and demonstrate its potential impact on the acute management of PSVT. Results are ...
MONTREAL and CHARLOTTE, N.C. - Milestone Pharmaceuticals Inc. (NASDAQ:MIST) announced plans for RESET-PSVT, a Phase 4 observational registry to collect real-world data on CARDAMYST (etripamil) nasal ...
Cardamyst (etripamil) is a nose spray that helps treat sudden episodes of fast heartbeats, known as paroxysmal supraventricular tachycardia (PSVT). PSVT is a type of abnormal heart rhythm where your ...
About 2 million Americans have a heart condition called “ paroxysmal supraventricular tachycardia ,” or PSVT. An electrical ...
MONTREAL and CHARLOTTE, N.C., March 20, 2026 (GLOBE NEWSWIRE)-- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of ...
Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development of commercialization of innovative cardiovascular medicines, today announced that management will ...
MONTREAL and CHARLOTTE, N.C., March 16, 2026 (GLOBE NEWSWIRE)-- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of ...
HONG KONG, Mar 23, 2026 - (ACN Newswire) – Everest Medicines today announced that it has entered into an Asset Purchase Agreement with Corxel Pharmaceuticals Hong Kong Limited. Under the agreement, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results